DOJ

AM Best Affirms Credit Ratings of Allianz México, S.A., Compañía de Seguros

Retrieved on: 
Thursday, June 2, 2022
Finance, Consulting, Banking, Professional Services, Insurance, DOJ, Life, ERM, Allianz, Insurance, Allianz Global Investors, Perception, News, Security (finance), U.S. Securities and Exchange Commission, U.S. Department of Defense Strategy for Operating in Cyberspace, AM Best, U.S. Department of Justice Office of Legislative Affairs, Health, AGI, AM, SEC, Credit, Industry, EUR, Superior, ALL, Drug, Risk management, S.A

AM Best has affirmed the Financial Strength Rating of A+ (Superior), the Long-Term Issuer Credit Rating of aa (Superior), and the Mexico National Scale Rating of aaa.MX (Exceptional) of Allianz Mxico, S.A., Compaa de Seguros (Allianz Mexico) (Mexico City, Mexico).

Key Points: 
  • AM Best has affirmed the Financial Strength Rating of A+ (Superior), the Long-Term Issuer Credit Rating of aa (Superior), and the Mexico National Scale Rating of aaa.MX (Exceptional) of Allianz Mxico, S.A., Compaa de Seguros (Allianz Mexico) (Mexico City, Mexico).
  • A change in AM Bests perception regarding the strategic importance of Allianz Mexico to the group also could impact Allianz Mexicos ratings.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Bests Credit Ratings .
  • For information on the proper use of Bests Credit Ratings, Bests Performance Assessments, Bests Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Bests Ratings & Assessments .

AM Best Affirms Credit Ratings of Allianz SE and Rated Subsidiaries

Retrieved on: 
Thursday, June 2, 2022
Insurance, Professional Services, DOJ, ERM, Allianz, Allianz Global Investors, Security (finance), U.S. Securities and Exchange Commission, U.S. Department of Defense Strategy for Operating in Cyberspace, FSR, AM Best, U.S. Department of Justice Office of Legislative Affairs, AGI, SEC, Credit, EUR, Superior, Proposed long-term solutions for the Eurozone crisis, Risk management

AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of aa (Superior) of Allianz SE (Germany) and its rated subsidiaries (see below for the list of the companies).

Key Points: 
  • AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of aa (Superior) of Allianz SE (Germany) and its rated subsidiaries (see below for the list of the companies).
  • The outlook of these Credit Ratings (ratings) is stable.
  • The ratings reflect Allianz SEs balance sheet strength, which AM Best assesses as strongest, as well as its strong operating performance, very favourable business profile and appropriate enterprise risk management (ERM).
  • Allianz SE had provisioned EUR 3.7 billion at the end of 2021 and EUR 1.9 billion at the end of the first quarter 2022.

Lost Money in Enochian Biosciences, Inc.?

Retrieved on: 
Thursday, June 2, 2022
Legal, Professional Services, DOJ, Invention, Hepatitis, Vaccine, Hindenburg Research, COVID-19, Woman, Lawyer, NASDAQ, MD, HIV, Doctor of Philosophy, Cancer, Ridesharing company, Private investigator, Pharmaceutical industry, Enochian

Gibbs Law Group is investigating a potential Enochian Securities Class Action Lawsuit on behalf of shareholders who lost money in Enochian Biosciences, Inc. (NASDAQ: ENOB).

Key Points: 
  • Gibbs Law Group is investigating a potential Enochian Securities Class Action Lawsuit on behalf of shareholders who lost money in Enochian Biosciences, Inc. (NASDAQ: ENOB).
  • According to Hindenburg, a key motive of the killing was a prospective merger deal that eventually led to Enochian Biosciences coming to market.
  • Enochian Biosciences itself appears to heavily rely on ideas and inventions by Dr. Gumruku, according to Hindenburg.
  • Our investigation concerns whether Enochian has violated federal securities laws by providing false or misleading statements to investors.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of The Gap, Inc. (GPS) on Behalf of Investors

Retrieved on: 
Wednesday, June 1, 2022
Legal, Professional Services, DOJ, Insurance, Gap Inc., Program, Rest, Old Navy, Financial Times, News, Press, Real estate investment trust, The Wall Street Journal, FDA, Publication, Person, Gap, Associated Press, NYSE, Bloomberg Businessweek, SCAS, GPM, SEC, Industry, GPS, Information technology, Security (finance), Pharmaceutical industry, Reuters, Forbes

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • On this news, Gaps stock fell $0.60, or 5.5%, to close at $10.33 per share on May 23, 2022, thereby injuring investors.
  • Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Enochian Biosciences, Inc. (ENOB) on Behalf of Investors

Retrieved on: 
Wednesday, June 1, 2022
Legal, Professional Services, DOJ, Insurance, Program, Financial Times, Hindenburg, News, Press, Real estate investment trust, Office of Inspector General, U.S. Department of Health and Human Services, The Wall Street Journal, FDA, Justice, Person, U.S. Department of Justice Office of Legislative Affairs, Publication, Hindenburg Research, Associated Press, Bloomberg Businessweek, SCAS, GPM, NASDAQ, SEC, Industry, Information technology, Research report, Pharmaceutical industry, Enochian, Reuters, Forbes

Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, continues its investigation on behalf of Enochian Biosciences, Inc. (Enochian or the Company) (NASDAQ: ENOB ) investors concerning the Companys possible violations of the federal securities laws.

Key Points: 
  • Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, continues its investigation on behalf of Enochian Biosciences, Inc. (Enochian or the Company) (NASDAQ: ENOB ) investors concerning the Companys possible violations of the federal securities laws.
  • On this news, Enochians stock fell $2.17, or 37%, to close at $3.70 per share on May 25, 2022, thereby injuring investors.
  • On this news, Enochians stock fell as much as 44.9% during intraday trading on June 1, 2022, thereby injuring investors further.
  • Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Novartis AG (NVS) on Behalf of Investors

Retrieved on: 
Wednesday, June 1, 2022
Legal, Professional Services, DOJ, Company, Insurance, Program, Food, Financial Times, News, Press, Real estate investment trust, The Wall Street Journal, FDA, Publication, Person, NVS, NYSE, Associated Press, Novartis, Bloomberg Businessweek, SCAS, GPM, SEC, Industry, Information technology, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Website, Pharmaceutical industry, Lutetium (177Lu) oxodotreotide, Reuters, Forbes

Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Novartis AG (Novartis or the Company) (NYSE: NVS ) investors concerning the Companys possible violations of the federal securities laws.

Key Points: 
  • Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Novartis AG (Novartis or the Company) (NYSE: NVS ) investors concerning the Companys possible violations of the federal securities laws.
  • On May 5, 2022, Novartis "announced a temporary, voluntary suspension of production at its radioligand therapy production sites in Ivrea, Italy and Millburn, New Jersey."
  • On this news, Novartis stock fell $2.06, or 2.3%, to close at $86.21 on May 5, 2022, thereby injuring investors.
  • Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.

Insurance Care Direct Responds to IRS Summons on Insurance Policies Carried by Company

Retrieved on: 
Monday, June 6, 2022
DOJ, ICD, Department, Justice, Multimedia, Company, Insurance, Internal Revenue Service, Health, Revenue stream, IRS, United States Department of Justice Tax Division, PLLC

DEERFIELD BEACH, Fla., June 6, 2022 /PRNewswire/ -- Insurance Care Direct (ICD), one of the nation's leading health benefits providers, today released the below statement in response to a summons enforcement action filed in federal court against corporate officers last month. The summonses, which were issued by the Internal Revenue Service (IRS), relate to captive insurance arrangements used by the company.

Key Points: 
  • The summonses, which were issued by the Internal Revenue Service (IRS), relate to captive insurance arrangements used by the company.
  • "Insurance Care Direct (ICD) and all corporate executives, including Seth Cohen, Brad Cohen and Ed Carriero, have fully cooperated with every request from the IRS.
  • Founded in 2001, Insurance Care Direct has grown into one of the largest health and life insurance agencies in the country.
  • Headquartered in Deerfield Beach, Florida, Insurance Care Direct is a family-owned business and is heavily involved in the local Florida community.

Paul Hastings Adds Renowned Financial Services Investigations, Regulation, and Litigation Team

Retrieved on: 
Thursday, June 2, 2022
Risk management, DOJ, Board, FDIC, The Legal 500, Lawyer, Enforcement, Brad Smith (American lawyer), Comptroller, Housing, Investigation, Federal Trade Commission, FTC, Private practice, OCC, Consumer, American, Federal Reserve Board of Governors, FRB, Consumer Financial Protection Bureau, National Credit Union Administration, The American Lawyer, American Bar Association, CFPB, NCUA, Chambers, Compliance, GIR, Federal Deposit Insurance Corporation, United States Secretary of Housing and Urban Development, Retail banking, Financial services, Industry, Department, Wall Street, California Department of Justice, HUD, Bank, Practice of law, Private investigator, Financial technology

NEW YORK and WASHINGTON, June 2, 2022 /PRNewswire/ -- Paul Hastings today announced the arrival of a high-profile team specializing in the representation of banks, non-bank financial institutions, fintechs, and other companies providing financial products and services.

Key Points: 
  • NEW YORK and WASHINGTON, June 2, 2022 /PRNewswire/ -- Paul Hastings today announced the arrival of a high-profile team specializing in the representation of banks, non-bank financial institutions, fintechs, and other companies providing financial products and services.
  • He also represents financial services companies in internal investigations and in class action litigation.
  • His understanding of the issues and risks facing financial services companies has made him a standout lawyer for the industry.
  • "Jonice, Matthew, Aaron, and Kari are superb lawyers who will excel across all aspects of regulatory and enforcement mattersfor our financial services clients," said Seth Zachary, chair of Paul Hastings.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed

Retrieved on: 
Tuesday, May 31, 2022
Physician, Risk, Fraud, Steve Berman (lawyer), Person, News, Defendant, NASDAQ, DOJ, Marketing, SAN, Lists of schools in England, Complaint, Program, False Claims Act, CDNA, Accusative case, SEC, GLOBE, Tobacco, Online gambling, Pharmaceutical industry

SAN FRANCISCO, May 31, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, May 31, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now .
  • CareDx, Inc. (CDNA) Securities Fraud Class Action:
    The complaint alleges that throughout the Class Period, CareDx reported growing revenue and strong demand in the Companys testing services segment.
  • If you invested in CareDx and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .
  • Hagens Berman is a global plaintiffs rights complex litigation law firm focusing on corporate accountability through class-action law.

NASA'S INSPECTOR GENERAL, PAUL MARTIN, TO BE FEATURED GUEST ON FEDERAL NEWS NETWORK'S "THE SEARCH FOR ACCOUNTABILITY" ON JUNE 6, HOSTED BY MICHAEL BINDER OF GRADUATE SCHOOL USA

Retrieved on: 
Tuesday, May 31, 2022
Georgetown University Law Center, U.S. Department of Justice Office of Legislative Affairs, Fraud, Nasdaq, Multimedia, Accountability, Pennsylvania State University, American Public University System, Justice, DOJ, 1500 AM, Commission, Radio, Efficiency, Office of Federal Financial Management, Partnership, Awareness, Office of Inspector General, U.S. Department of Health and Human Services, NASA, Binder, GSUSA, IG, Program, State school, Graduate School USA, National Aeronautics and Space Act, WFED, Special counsel, Graduate school, OIG, Federal Financial Supervisory Authority, News, APEI, Journalism, Medicine

ET on Federal News Network 1500 AM, hosted by Michael Binder, Director of Graduate School USA's Government Audit Training Institute and Federal Financial Management programs.

Key Points: 
  • ET on Federal News Network 1500 AM, hosted by Michael Binder, Director of Graduate School USA's Government Audit Training Institute and Federal Financial Management programs.
  • ET., is produced in a partnership between Graduate School USA and Federal News Network.
  • Graduate School USA is a leading training provider to the federal workforce with an extensive portfolio of government agency customers.
  • It serves the federal workforce through customized contract training (B2G) to federal agencies and through open enrollment (B2C) to government professionals.